Introducing the STYL'One Nano R&D tablet press from Medelpharm, a benchtop-sized compact solution to cater...
New R&D-stage lineup addresses longstanding challenges, from early stage powder characterisation and formulation development to scale-up and production support. Lyon, France – MEDELPHARM, the global leader in the development of compaction simulator technology – has announced a strategic partnership with KORSCH AG – the global leader in tablet press technology, offering solutions for product development, scale-up, high-speed production, multi-layer, mini-tablet, and WIP / high-containment applications, to introduce a new portfolio of equipment geared to R&D stage production. The collaboration includes a joint microsite dedicated to the new R&D lineup: www.r-d-in-focus.com.
Leveraging the companies’ combined 135-plus years of experience with small-scale, fully instrumented machines, the R&D product portfolio addresses and overcomes longstanding challenges, from early stage powder characterisation and formulation development to scale-up and production support. The combined KORSCH-MEDELPHARM R&D product equipment lineup includes:
- XP 1: Robust single-punch tablet press with small-batch capabilities
- STYL’One Nano: Benchtop compaction simulator with integrated analytical software, for single-layer formulation development
- STYL’One Evo: Advanced compaction simulator with integrated analytical software and multi-layer capability, allowing R&D at production speed
- XL 100: Small-scale rotary press for product development and clinical batch production
Covering the full spectrum of tabletting technology from single-layer to five-layer as well as core coating capabilities, the new R&D product equipment portfolio serves as a versatile complement to KORSCH’s multilayer production machinery. Notably, the STYL’One Evo offers the ability to simulate all high-speed production presses to predict product performance with minimal material quantities.
Like the MEDELPHARM Science Laboratory in Lyon, France, the KORSCH Innovation Centers in Berlin and Boston have installed the STYL’One Evo and STYL’One Nano machines for demonstration, testing and, by simulating the full range of KORSCH production equipment, product trials with predictive results. The facilities in Lyon and Berlin also are offering contract services including formulation optimisation, powder analysis, and material characterisation.
MEDELPHARM is the designer and proprietor of STYL’One hardware and software technology. Under the agreement, MEDELPHARM equipment and software will continue to be designed, developed, and manufactured in Lyon, France. With an existing global customer base of nearly 200 machines, MEDELPHARM STYL’One technology will be supported by the KORSCH global technical service network with OEM spare part inventories in Berlin and Boston.
To support worldwide distribution, KORSCH will offer the fully combined R&D product equipment lineup on a global basis with the exception of France and Belgium. In those countries, MEDELPHARM has exclusive rights to distribute the new line, as well as the full range of KORSCH production equipment, in addition to its current representation of LB Bohle and other complementary technology brands.
For more information, please fill out the enquiry form attached to this page.
Tableting has never been so easy and so powerful, from pure API characterisation to formulation...
Mini-tablets, smaller than 3 mm in diameter, an innovative trend in solid dosage form design,...
Medelpharm is pleased to announce the release of Alix, an innovative integrated worldwide R&D platform...